Announcement time of this financial report: 2023-10-23 20:00:41

Robust Healthcare (Stock Code: 300888) is a medical company specializing in the research, development, production and sales of medical equipment. According to the three quarterly reports of 2023, the company achieved certain investment income and other income in the first half of the year, but whether these gains are sustainable or not needs further observation and analysis.

In terms of assets and liabilities, the total assets of healthy Medical Services at the end of the third quarter of 2023 were 19.059 billion yuan, an increase compared with 18.363 billion yuan at the end of last year. The total liabilities were 5.399 billion yuan, down from 6.165 billion yuan at the end of last year. The net asset was 13.66 billion yuan, an increase compared with 12.198 billion yuan at the end of last year. The asset-liability ratio was 28.33%, down from 33.57% at the end of the previous year. These data show that the company's assets are in good condition and its debt level is under control.

In terms of profit, the company's operating income in the third quarter of 2023 was 6.01 billion yuan, down from 7.642 billion yuan in the same period last year. The operating profit was 2.557 billion yuan, up from 1.484 billion yuan in the same period last year. The net profit was 2.186 billion yuan, a substantial increase compared with 1.267 billion yuan in the same period last year. These data show that although the company's operating revenue has declined, it has achieved a substantial increase in profits through effective cost control.

In terms of cash flow, the net cash flow generated by the company's operating activities in the third quarter of 2023 was 222 million yuan, down significantly from 1.208 billion yuan in the same period last year. It is mainly due to the decrease in sales revenue of infection protection products in the medical sector and the decline in gross profit margin brought about by changes in the structure of medical products.

Generally speaking, healthy Medical has a good operating condition in the third quarter of 2023. Although the operating income has declined, it has achieved a substantial increase in profits through effective cost control. However, the company's net cash flow has dropped significantly, which may be due to the decrease in customer payment in advance and the higher payment of last year's tax and payment in the current period, which deserves the attention of investors.

For investors, the overall financial position of sound health care is sound, and the substantial increase in net profit shows that the company is highly profitable. However, the sharp decline in net cash flow may have an impact on the company's day-to-day operations, which requires the close attention of investors. It is suggested that when making investment decisions, investors should pay attention not only to the profitability of the company, but also to the cash flow of the company.

This article only represents the judgment made by the analyst himself or the analyst on the basis of AI analysis, and can not be used as any investment index, nor does it constitute any investment advice. The original intention of this paper is to help investors analyze and judge the capital market data in the most intuitive and fast way and from the most professional perspective.